Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Malassezia infection may cause refractory acne, and antifungal treatments can help.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Hair follicle stem cells can become neural cells using different methods, with varying efficiency.

Galla chinensis solution effectively treats fungal skin infections in dogs.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document says to treat cat fungal infections with medicine and clean the environment, noting that cats without symptoms can still spread it to humans.

Lack of a key enzyme causes severe skin issues and death in mice.

Canakinumab's effect on COVID-19 outcomes is unclear.

Booster doses of Covaxin improve protection against the Omicron variant.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Dermabrasion is a safe, effective way to improve skin appearance with minimal recovery time.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

Certain gene variants are linked to severe acne, especially in males.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

Intradermal microbotox injections work better and last longer for reducing large facial pores than topical application.